mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.16 |
0.6 |